GB202002639D0 - Therapy - Google Patents

Therapy

Info

Publication number
GB202002639D0
GB202002639D0 GBGB2002639.9A GB202002639A GB202002639D0 GB 202002639 D0 GB202002639 D0 GB 202002639D0 GB 202002639 A GB202002639 A GB 202002639A GB 202002639 D0 GB202002639 D0 GB 202002639D0
Authority
GB
United Kingdom
Prior art keywords
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2002639.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Business Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Business Ltd filed Critical UCL Business Ltd
Priority to GBGB2002639.9A priority Critical patent/GB202002639D0/en
Publication of GB202002639D0 publication Critical patent/GB202002639D0/en
Priority to EP21708345.0A priority patent/EP4110311A1/en
Priority to PCT/GB2021/050429 priority patent/WO2021170982A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/11Aldehydes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB2002639.9A 2020-02-25 2020-02-25 Therapy Ceased GB202002639D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB2002639.9A GB202002639D0 (en) 2020-02-25 2020-02-25 Therapy
EP21708345.0A EP4110311A1 (en) 2020-02-25 2021-02-22 Therapy
PCT/GB2021/050429 WO2021170982A1 (en) 2020-02-25 2021-02-22 Therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2002639.9A GB202002639D0 (en) 2020-02-25 2020-02-25 Therapy

Publications (1)

Publication Number Publication Date
GB202002639D0 true GB202002639D0 (en) 2020-04-08

Family

ID=70108433

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2002639.9A Ceased GB202002639D0 (en) 2020-02-25 2020-02-25 Therapy

Country Status (3)

Country Link
EP (1) EP4110311A1 (en)
GB (1) GB202002639D0 (en)
WO (1) WO2021170982A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
US6036986A (en) * 1997-10-28 2000-03-14 Lipton, Division Of Conopco, Inc. Cinnamic acid for use in tea containing beverages
EP2583568A1 (en) * 2011-10-18 2013-04-24 Purac Biochem N.V. Preservative combinations comprising vanillin and cinnamic acid
CN107021844A (en) * 2017-06-06 2017-08-08 芜湖亨益汽车运输有限公司 One kind promotes grape growth organic fertilizer and preparation method thereof
CN108713635A (en) * 2018-03-31 2018-10-30 陆川县米场镇华屋竹鼠养殖场 A kind of bamboo rat fattening feed and preparation method thereof
CN108740170A (en) * 2018-07-27 2018-11-06 福州东升茶厂 A kind of formula of tea beverage and preparation method thereof
CN113473981A (en) * 2019-02-25 2021-10-01 拉什大学医学中心 Cinnamic acid containing compositions and methods of use thereof

Also Published As

Publication number Publication date
WO2021170982A1 (en) 2021-09-02
EP4110311A1 (en) 2023-01-04

Similar Documents

Publication Publication Date Title
GB202001980D0 (en) Therapeutic mentods
GB202006960D0 (en) Therapeutic
GB202108303D0 (en) Therapy
GB202111288D0 (en) Combination therapy
GB202004189D0 (en) Combination therapy
GB202117706D0 (en) Therapy
GB202111035D0 (en) Therapy
GB202109893D0 (en) PeptiBAC therapy
GB202104427D0 (en) Therapy
GB202103164D0 (en) Therapy
GB202102211D0 (en) PeptiBAC therapy
GB202019218D0 (en) Therapy
GB202017598D0 (en) Therapy
GB202017554D0 (en) Therapy
GB202015780D0 (en) Therapy
GB202015778D0 (en) Therapy
GB202013824D0 (en) PeptiBAC therapy
GB202013834D0 (en) PeptiVAX therapy
GB202009039D0 (en) Therapy
GB202008031D0 (en) Therapy
GB202004629D0 (en) Therapy
GB202004013D0 (en) Therapy
GB202002639D0 (en) Therapy
GB202001905D0 (en) Therapy
IL304223A (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)